Finally, germline mutations in Breast Cancer Gene 1 (BRCA1), Breast Cancer Gene 2 (BRCA2), BRCA1 interacting Protein 1 (BRP1), Partner and Localizer of BRCA2 (PALB2), RAD51 homolog C (RAD51C), RAD51 homolog D (RAD51D), and individuals with Lynch syndrome are susceptible to ovarian cancers [7,8,9]. This evidence concerns the gene BRCA2 and Lynch syndrome.